Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial
Crossref DOI link: https://doi.org/10.1186/s12931-017-0622-x
Published Online: 2017-07-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vogelmeier, Claus F.
,
Gaga, Mina
Aalamian-Mattheis, Maryam
Greulich, Timm
Marin, Jose M.
Castellani, Walter
Ninane, Vincent
Lane, Stephen
Nunez, Xavier
Patalano, Francesco
Clemens, Andreas
Kostikas, Konstantinos
Funding for this research was provided by:
Novartis